|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 9/16 | |
| A61K 47/10 | |||
| A61K 47/34 | |||
| A61K 31/5575 |
| (11) | Number of the document | 3062775 |
| (13) | Kind of document | T |
| (96) | European patent application number | 14802985.3 |
| Date of filing the European patent application | 2014-10-31 | |
| (97) | Date of publication of the European application | 2016-09-07 |
| (45) | Date of publication and mention of the grant of the patent | 2017-12-06 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2014/063569 |
| Date | 2014-10-31 |
| (87) | Number | WO 2015/066548 |
| Date | 2015-05-07 |
| (30) | Number | Date | Country code |
| 201361898241 P | 2013-10-31 | US |
| (72) |
GHEBREMESKEL, Alazar N., US
ROBINSON, Michael R., US
|
| (73) |
ALLERGAN, INC.,
2525 Dupont Drive, Irvine, CA 92612,
US
|
| (54) | PROSTAMIDE-CONTAINING INTRAOCULAR IMPLANTS AND METHODS OF USE THEREOF |
| PROSTAMIDE-CONTAINING INTRAOCULAR IMPLANTS AND METHODS OF USE THEREOF |